, Smith & Nephew, Boston Scientific, Johnson & Johnson. and Abbott UPDATED EFTA00810555 u 1 Prostate Cancer - Novel Medicines EFTA00810556 Zuclomiphene: potential to be the first FDA approved drug for hot flashes caused by prostate cancer hormone therapy Hot flashes are one of the most common and